Santhera Pharmaceuticals
Clinical trials sponsored by Santhera Pharmaceuticals, explained in plain language.
-
New hope for duchenne: safer steroid alternative shows promise in boys
Disease control CompletedThis study tested a drug called vamorolone in 54 boys with Duchenne muscular dystrophy (DMD), a muscle-weakening disease. The goal was to see if the drug is safe and can help control the disease with fewer side effects than standard steroids. Boys aged 2 to under 4 and 7 to under…
Phase: PHASE2 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 08:02 UTC
-
Healthy volunteers help scientists check vamorolone's effect on body's salt control
Knowledge-focused CompletedThis completed early-stage study looked at whether the drug vamorolone can block a receptor in the body that controls salt and water balance. Thirty healthy adults took part, and researchers measured the levels of sodium and potassium in their urine over two days. The goal was to…
Phase: PHASE1 • Sponsor: Santhera Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 08:00 UTC
-
New drug interaction study completed in healthy volunteers
Knowledge-focused CompletedThis study looked at whether vamorolone changes how the body breaks down other drugs, using midazolam as a test. Eighteen healthy adults took part. The goal was to measure drug levels in the blood before and after taking vamorolone to see if there is an interaction.
Phase: PHASE1 • Sponsor: Santhera Pharmaceuticals • Aim: Knowledge-focused
Last updated May 05, 2026 11:55 UTC